JPMORGAN CHASE & CO - 31 Mar 2025 SCHEDULE 13G Report for KEROS THERAPEUTICS, INC. Common Stock, $0.0001 par value per share (KROS)

Filing Manager: JPMORGAN CHASE & CO
Reporting Manager: JPMORGAN CHASE & CO.
Security: KEROS THERAPEUTICS, INC. Common Stock, $0.0001 par value per share
Symbol: KROS
Shares outstanding: 41,065,810 shares
Disclosed Ownership: 2,587,146 shares
Ownership: 6.3%
Form type: SCHEDULE 13G
Filing time: 02 May 2025, 09:59:54 UTC
Date of event: 31 Mar 2025
Next filing: 05 May 2025
SEC: View on sec.gov

Reporting Managers (1)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
JPMORGAN CHASE & CO.	6.3%	2,587,146	2,587,146	0	Rachel Tsvaygoft	Vice President